Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), 2020 | 2526 | 2020 |
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), 2020 | 2172 | 2020 |
Regulation of human NK-cell cytokine and chemokine production by target cell recognition C Fauriat, EO Long, HG Ljunggren, YT Bryceson Blood 115 (11), 2167-2176, 2010 | 1044 | 2010 |
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion YT Bryceson, ME March, HG Ljunggren, EO Long Blood 107 (1), 159-166, 2006 | 1030 | 2006 |
The immunology of multisystem inflammatory syndrome in children with COVID-19 CR Consiglio, N Cotugno, F Sardh, C Pou, D Amodio, L Rodriguez, Z Tan, ... Cell 183 (4), 968-981. e7, 2020 | 918 | 2020 |
Activation, coactivation, and costimulation of resting human natural killer cells YT Bryceson, ME March, HG Ljunggren, EO Long Immunological reviews 214 (1), 73-91, 2006 | 782 | 2006 |
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function H Schlums, F Cichocki, B Tesi, J Theorell, V Beziat, TD Holmes, H Han, ... Immunity 42 (3), 443-456, 2015 | 738 | 2015 |
Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells YT Bryceson, ME March, DF Barber, HG Ljunggren, EO Long Journal of Experimental Medicine 202 (7), 1001-1012, 2005 | 602 | 2005 |
CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin S Cheuk, H Schlums, IG Sérézal, E Martini, SC Chiang, N Marquardt, ... Immunity 46 (2), 287-300, 2017 | 566 | 2017 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 456 | 2021 |
Activation of NK cells by an endocytosed receptor for soluble HLA-G S Rajagopalan, YT Bryceson, SP Kuppusamy, DE Geraghty, ... PLoS biology 4 (1), e9, 2005 | 397 | 2005 |
Defective cytotoxic lymphocyte degranulation in syntaxin-11–deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients YT Bryceson, E Rudd, C Zheng, J Edner, D Ma, SM Wood, ... Blood 110 (6), 1906-1915, 2007 | 370 | 2007 |
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors YT Bryceson, HG Ljunggren, EO Long Blood 114 (13), 2657-2666, 2009 | 364 | 2009 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science Immunology 6 (62), eabl4348, 2021 | 342 | 2021 |
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes YT Bryceson, D Pende, A Maul-Pavicic, KC Gilmour, H Ufheil, T Vraetz, ... Blood 119 (12), 2754-2763, 2012 | 333 | 2012 |
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells M Carlsten, NK Björkström, H Norell, Y Bryceson, T van Hall, ... Cancer research 67 (3), 1317-1325, 2007 | 311 | 2007 |
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells M Carlsten, H Norell, YT Bryceson, I Poschke, K Schedvins, ... The Journal of Immunology 183 (8), 4921-4930, 2009 | 299 | 2009 |
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3 EM Haapaniemi, M Kaustio, HLM Rajala, AJ van Adrichem, L Kainulainen, ... Blood 125 (4), 639-648, 2015 | 294 | 2015 |
Natural killer cell-mediated immunosurveillance of human cancer KJ Malmberg, M Carlsten, A Björklund, E Sohlberg, YT Bryceson, ... Seminars in Immunology, 2017 | 270 | 2017 |
Molecular mechanisms of natural killer cell activation YT Bryceson, SCC Chiang, S Darmanin, C Fauriat, H Schlums, J Theorell, ... Journal of innate immunity 3 (3), 216-226, 2011 | 260 | 2011 |